Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs Odyssey Therapeutics, Inc. (ODTX)

Janux Therapeutics, Inc. and Odyssey Therapeutics, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and Odyssey Therapeutics, Inc. are of similar size ($981.9M and $907.3M). Odyssey Therapeutics, Inc. has the higher net margin (0.00% vs −300.0%) and the lower return on invested capital (−238.8% vs 0.00%). Across the 10 metrics below, Janux Therapeutics, Inc. leads on 5 and Odyssey Therapeutics, Inc. on 5.

Valuation

Metric JANX ODTX Biotechnology median
P/E n/m n/m 10.60
P/S 33.41 n/m 9.40
P/B 1.22 2.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.00 n/m 9.02
Earnings yield (9.02%) (90.93%) (32.88%)
Free cash flow yield (4.87%) (16.19%) (23.13%)

Profitability

Metric JANX ODTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (419.24%) 0.00% 0.00%
Net margin (299.95%) 0.00% 0.00%
Free cash flow margin (162.70%) 0.00% 0.00%
Return on equity (10.58%) 0.00% (51.96%)
Return on assets (9.94%) 0.00% (46.06%)
Return on invested capital 0.00% (238.81%) 0.00%

Growth

Metric JANX ODTX Biotechnology median
Revenue growth (TTM) 214.40% — 6.76%
EPS growth (last fiscal year) (42.97%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JANX ODTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.69 12.94 4.97
Net debt to EBITDA 5.58 — 1.01

Dividend

Metric JANX ODTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JANX ODTX Biotechnology median
Market cap 981.86m 907.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack